BRIGHT MINDS BIOSCIENCES

Company snapshot

BRIGHT MINDS BIOSCIENCES maintains 1063 tracked programs across Cocaine-Related Disorders, Cocaine Dependence, Nicotine Dependence, Tobacco Use Disorder, Opioid Use Disorder, HIV Infections, Smoking Cessation, Substance-Related Disorders, Opioid-Related Disorders, Cocaine Use Disorder, Smoking, Substance Abuse. Momentum score: 20/100 (30-day delta: n/a). Public registry data covers pipeline phase,

• 2 approved product(s) across US/EU regulatory metadata.
• 1063 active pipeline program(s) linked via ClinicalTrials.gov.
• 57 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for BRIGHT MINDS BIOSCIENCES. Not investment advice.

• Peer + 0 momentum

  Indivior Pty

  TA overlap score 27.8

Recent activity

Latest pipeline, patent, and corporate events for BRIGHT MINDS BIOSCIENCES.

1. Jun 8, 2026 Clinical update

   R01DA029050 — Phase 2

2. Jun 8, 2026 Clinical update

   811095 — Phase 3

3. Jun 8, 2026 Clinical update

   GDCRI/ACM/PG/PhD/10/2013-14 — Phase 2

4. Jun 8, 2026 Clinical update

   KLWS-V502-04 — Phase 3

5. Jun 8, 2026 Clinical update

   KLWS-V502-02 — Phase 2

View all clinical trial activity →

• What is BRIGHT MINDS BIOSCIENCES?

  Bright Minds Biosciences is a pharma organization headquartered in New York, USA. It trades on NYSE under ticker DRUG. Primary therapeutic focus areas include Cocaine-Related Disorders, Cocaine Dependence, Nicotine Dependence, Tobacco Use Disorder, Opioid Use Disorder. NovaPharma

• Is BRIGHT MINDS BIOSCIENCES publicly traded?

  Yes. BRIGHT MINDS BIOSCIENCES is listed with ticker DRUG on NYSE per SEC EDGAR records linked on this profile.

• What drugs does BRIGHT MINDS BIOSCIENCES develop or market?

  We link 444 drug profile(s) where BRIGHT MINDS BIOSCIENCES is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/bright-minds-biosciences-inc#company-drugs.

• What are the latest developments for BRIGHT MINDS BIOSCIENCES?

  In the last 12 months our linked public records show 1063 trial program update(s) and 2 US patent grant(s) tied to this profile.

• What therapeutic areas does BRIGHT MINDS BIOSCIENCES focus on?

  BRIGHT MINDS BIOSCIENCES focuses on Cocaine-Related Disorders, Cocaine Dependence, Nicotine Dependence based on our analysis of their pipeline programs and drug development activities.